HCG

Healthcare Global Enterprises Limited

Healthcare Global Enterprises Limited (HCG) financial statements and selected valuation metrics through 30 June 2026.

Healthcare›Healthcare›Healthcare Services›Hospital

hcgoncology.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹588.20
Market cap
8,804 Cr
Stock P/E
386.5
P/B
6.59
ROE (FY26)
1.0%
ROCE (FY26)
8.8%
Operating margin (FY26)
8.7%
Debt / equity (FY26)
0.68
OCF / EBITDA (FY26)
74.5%
OCF / EBITDA (3Y)
80.2%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

HCG (Healthcare Global Enterprises) runs a network of cancer-care hospitals in India, treating patients through medical, surgical and radiation oncology and charging patients and institutional payors for care.

Company snapshot

13thBy market cap

Ranked among 24 companies in Hospital.

What we see

Concerns
  • ✗Net margin is very thin at 0.9% — little room for error if costs rise.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales487 Cr470 Cr495 Cr526 Cr554 Cr558 Cr585 Cr613 Cr647 Cr633 Cr652 Cr695 Cr
Operating expenses (approx.)402 Cr391 Cr403 Cr435 Cr451 Cr470 Cr479 Cr505 Cr524 Cr523 Cr527 Cr573 Cr
EBITDA85 Cr79 Cr92 Cr91 Cr102 Cr87 Cr106 Cr108 Cr123 Cr110 Cr125 Cr122 Cr
OPM %17.4%16.7%18.6%17.3%18.5%15.7%18.1%17.6%19.1%17.3%19.2%17.6%
Other income3 Cr6 Cr5 Cr9 Cr11 Cr6 Cr10 Cr7 Cr3 Cr2 Cr13 Cr12 Cr
Interest27 Cr29 Cr27 Cr34 Cr36 Cr41 Cr44 Cr45 Cr44 Cr45 Cr43 Cr40 Cr
Depreciation43 Cr44 Cr46 Cr47 Cr50 Cr57 Cr58 Cr58 Cr63 Cr61 Cr63 Cr70 Cr
Profit before tax18 Cr11 Cr28 Cr19 Cr28 Cr-3 Cr14 Cr12 Cr20 Cr-6 Cr1 Cr25 Cr
Tax %39.8%69.0%16.9%28.2%25.2%334.8%50.3%49.8%-4.2%-30.1%-223.2%34.2%
Net profit11 Cr3 Cr23 Cr14 Cr21 Cr8 Cr7 Cr6 Cr21 Cr-8 Cr4 Cr16 Cr
EPS (₹)₹0.98₹0.41₹1.53₹0.87₹1.29₹0.50₹0.53₹0.34₹1.16₹-0.68₹0.15₹0.92

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales700 Cr831 Cr976 Cr1,096 Cr1,013 Cr1,398 Cr1,694 Cr1,912 Cr2,223 Cr2,545 CrSign in free for the trailing twelve months
Operating expenses (approx.)595 Cr712 Cr853 Cr923 Cr887 Cr1,160 Cr1,396 Cr1,583 Cr1,836 Cr2,080 CrSign in free for the trailing twelve months
EBITDA105 Cr119 Cr123 Cr172 Cr127 Cr238 Cr299 Cr330 Cr387 Cr466 CrSign in free for the trailing twelve months
OPM %15.0%14.3%12.6%15.7%12.5%17.0%17.6%17.2%17.4%18.3%Sign in free for the trailing twelve months
Other income10 Cr13 Cr10 Cr7 Cr17 Cr13 Cr13 Cr17 Cr35 Cr25 CrSign in free for the trailing twelve months
Interest23 Cr42 Cr70 Cr138 Cr119 Cr98 Cr104 Cr109 Cr155 Cr177 CrSign in free for the trailing twelve months
Depreciation57 Cr71 Cr85 Cr148 Cr159 Cr158 Cr163 Cr174 Cr211 Cr244 CrSign in free for the trailing twelve months
Profit before tax35 Cr27 Cr-33 Cr-119 Cr-229 Cr88 Cr45 Cr68 Cr57 Cr27 CrSign in free for the trailing twelve months
Tax %33.9%37.7%7.5%-5.2%3.3%55.7%60.7%39.0%14.3%15.4%Sign in free for the trailing twelve months
Net profit23 Cr17 Cr-31 Cr-125 Cr-221 Cr39 Cr18 Cr41 Cr49 Cr23 CrSign in free for the trailing twelve months
EPS (₹)₹2.69₹2.38₹-2.82₹-12.05₹-17.02₹4.14₹2.11₹3.46₹3.19₹0.97Sign in free for the trailing twelve months
Dividend payout %—————0.0%0.0%0.0%0.0%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital86 Cr87 Cr88 Cr89 Cr125 Cr139 Cr139 Cr139 Cr139 Cr149 Cr
Reserves347 Cr428 Cr458 Cr293 Cr572 Cr731 Cr721 Cr686 Cr783 Cr1,183 Cr
Borrowings325 Cr374 Cr567 Cr1,254 Cr919 Cr408 Cr399 Cr673 Cr1,002 Cr910 Cr
Other liabilities411 Cr490 Cr564 Cr579 Cr403 Cr928 Cr1,047 Cr1,170 Cr1,551 Cr1,602 Cr
Total liabilities1,226 Cr1,444 Cr1,723 Cr2,253 Cr2,036 Cr2,220 Cr2,316 Cr2,708 Cr3,543 Cr3,923 Cr
Fixed assets (net)617 Cr713 Cr852 Cr1,505 Cr1,265 Cr1,336 Cr1,353 Cr1,505 Cr1,963 Cr2,041 Cr
CWIP148 Cr174 Cr153 Cr46 Cr30 Cr22 Cr18 Cr83 Cr25 Cr19 Cr
Investments11 Cr53 Cr49 Cr34 Cr26 Cr9 Cr10 Cr10 Cr11 Cr14 Cr
Loans & advances——14 Cr5 Cr9 Cr2 Cr2 Cr2 Cr3 Cr3 Cr
Inventories19 Cr24 Cr27 Cr23 Cr21 Cr30 Cr38 Cr43 Cr53 Cr60 Cr
Trade receivables103 Cr128 Cr157 Cr186 Cr187 Cr217 Cr303 Cr294 Cr401 Cr421 Cr
Cash & bank85 Cr29 Cr21 Cr32 Cr30 Cr198 Cr175 Cr273 Cr236 Cr536 Cr
Other assets243 Cr323 Cr451 Cr422 Cr468 Cr406 Cr418 Cr497 Cr852 Cr829 Cr
Total assets1,226 Cr1,444 Cr1,723 Cr2,253 Cr2,036 Cr2,220 Cr2,316 Cr2,708 Cr3,543 Cr3,923 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity91 Cr98 Cr99 Cr130 Cr121 Cr220 Cr252 Cr285 Cr317 Cr347 Cr
Cash from investing-210 Cr-282 Cr-238 Cr-101 Cr-171 Cr125 Cr-133 Cr-226 Cr-488 Cr-177 Cr
Cash from financing89 Cr161 Cr84 Cr-58 Cr112 Cr-155 Cr-140 Cr-64 Cr-42 Cr241 Cr
Net cash flow-29 Cr-23 Cr-56 Cr-30 Cr62 Cr190 Cr-22 Cr-5 Cr-213 Cr410 Cr
Free cash flow (OCF − Capex)-101 Cr-158 Cr-90 Cr22 Cr85 Cr149 Cr118 Cr99 Cr108 Cr55 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %7.1%7.3%3.2%1.1%-6.7%14.4%11.7%11.5%10.6%8.8%
ROE %4.5%2.9%-4.2%-25.4%-27.1%6.1%3.4%5.6%4.5%1.0%
Debtor days54565962675765566660
Inventory days1011108888899
Days payable66626851525153545550
Cash conversion cycle-34118221420112019
OCF / EBITDA %86.9%82.3%80.4%75.6%95.2%92.5%84.2%86.3%81.9%74.5%
OCF / EBITDA % (3 years)——83.0%78.9%82.9%87.7%89.3%87.3%84.0%80.2%
Debt / equity0.750.731.043.291.320.470.460.811.090.68
Current ratio0.670.610.600.531.031.071.020.910.811.09
Net debt / EBITDA2.28—4.467.107.020.880.751.211.980.80